查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571679

蛋白质结合测定市场规模、份额、趋势分析报告：按技术、按产品和服务、按最终用途、按地区、细分市场预测，2024-2030 年

Protein Binding Assays Market Size, Share & Trends Analysis Report By Technology (Ultrafiltration, Ultracentrifugation), By Product & Services (Instrument), By End Use (CROs), By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格
简介目录

蛋白质结合测定市场成长与趋势：

根据 Grand View Research, Inc. 的最新报告，预计到 2030 年，全球蛋白结合检测市场规模将达到 8.963 亿美元，2024 年至 2030 年复合年增长率为 10.2%。

蛋白质结合测定越来越多地应用于药物发现和开发项目的临床前阶段。这些测定有助于检测目标分子并提供有关治疗剂和生技药品特性的重要资讯。

製药公司增加治疗药物开发的研发外包预计将增加蛋白质结合测定的采用。提供这些分子研究和分析服务的多家公司的存在预计将对预测期内的市场成长产生积极影响。

这些测定对于了解候选治疗药物的选择和开发中的 ADME 特性非常有用。估计药物开发过程中的安全裕度是一个重要的步骤，可以透过量化新化学物质与蛋白质的结合来完成。

蛋白质结合测定市场报告亮点

  • 2023年，市场占有率。技术进步、策略性投资和不断增长的消费者需求构成了市场成长。
  • 到 2023 年，平衡透析将占据主导地位，份额为 49.7%。科学家和研究人员更喜欢这项技术，因为它成本低且准确度高。
  • 2023年，製药和生物技术产业占46.4%的份额。广泛而强大的分销网络以及对药物发现的大量投资等因素正在推动该细分市场的成长。
  • 北美蛋白质结合检测在 2023 年以 40.8% 的份额主导全球市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第 3 章蛋白质结合测定市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 蛋白质结合分析市场分析工具
    • 波特的分析
    • PESTEL分析

第四章 蛋白结合分析市场：产品和服务的估计和趋势分析

  • 细分仪表板
  • 蛋白质结合分析市场：2023 年和 2030 年产品与服务变化分析
  • 装置
  • 试剂套件和试剂
  • 服务

第五章 蛋白质结合检测市场：技术评估与趋势分析

  • 细分仪表板
  • 蛋白质结合分析市场：2023 年和 2030 年技术变化分析
  • 超速离心
  • 平衡透析
  • 超过滤
  • 表面等离子体共振
  • 其他的

第六章蛋白质结合测定市场：最终用途估计与趋势分析

  • 细分仪表板
  • 蛋白质结合分析市场：最终用途变异分析，2023 年和 2030 年
  • 受託研究机构
  • 製药和生物技术公司
  • 其他的

第七章蛋白质结合检测市场：区域估计与趋势分析

  • 2023 年和 2030 年蛋白质结合检测市场占有率（按地区）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特
    • 南非

第八章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Thermo Fisher Scientific
    • ADMEcell, Inc
    • Beckman Coulter, Inc
    • Sartorius Stedim BioOutsource Limited
    • Bio-Rad Laboratories, Inc
    • Abzena Ltd
    • Abcam Plc
    • GVK Biosciences Private Limited
    • Promega Corporation
    • Arryait Corporation
    • Charles River Laboratories
    • Sovicell
    • Eurofins Scientific
    • 3B Pharmaceuticals
    • Creative Biolabs
    • Evotec SE
    • BioDuro-Sundia
    • Merck KGaA
简介目录
Product Code: GVR-3-68038-593-9

Protein Binding Assays Market Growth & Trends:

The global protein binding assays market size is expected to reach USD 896.3 million by 2030 at a CAGR of 10.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Protein binding assays are increasingly being adopted in preclinical stages of drug discovery & development programs. These assays help in detection of target molecules and provide critical information about the properties of therapeutics and biologics.

Increase in number of R&D outsourcing activities by pharmaceutical companies for development of therapeutics is anticipated to increase the adoption of protein binding assays. Presence of several companies that provide these services for molecule investigation and analysis is expected to positively impact the market growth over the forecast period.

These assays provide help understand ADME properties during selection and development of therapeutic candidates. Estimation of safety margins during drug development is an important step that can be carried out by quantification of binding of new chemical entities to a protein.

Protein Binding Assays Market Report Highlights:

  • The services segment dominated with a market share of 44.7% in 2023. Technological advancements, strategic investments, and increasing consumer demand constitute market growth.
  • The equilibrium dialysis dominated with a share of 49.7% in 2023. Scientists and researchers prefer this technique due to its low price and high accuracy.
  • The pharmaceuticals and biotechnology segment dominated with a 46.4% market share in 2023. Factors such as a wide and strong distribution network and significant investments in drug discovery boost the segment growth.
  • The North America protein binding assays dominated the global market with a share of 40.8% in 2023.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Protein Binding Assay Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Protein Binding Assay Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining Power of the Suppliers
      • 3.4.1.2. Bargaining Power of the Buyers
      • 3.4.1.3. Threats of Substitution
      • 3.4.1.4. Threats From New Entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Protein Binding Assay Market: Product & Services Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Protein Binding Assay Market: Product & Services Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Instrument
    • 4.3.1. Instrument Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Kits & Reagents
    • 4.4.1. Kits & Reagents Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Services
    • 4.5.1. Services Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Protein Binding Assay Market: Technology Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Protein Binding Assay Market: Technology Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Ultracentrifugation
    • 5.3.1. Ultracentrifugation Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Equilibrium Dialysis
    • 5.4.1. Equilibrium Dialysis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ultrafiltration
    • 5.5.1. Ultrafiltration Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Surface Plasmon Resonance
    • 5.6.1. Surface Plasmon Resonance Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Protein Binding Assay Market: End Use Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Protein Binding Assay Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
  • 6.3. Contract Research Organizations
    • 6.3.1. Contract Research Organizations Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Pharmaceutical & Biotechnology Companies
    • 6.4.1. Pharmaceutical & Biotechnology Companies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Protein Binding Assay Market: Regional Estimates & Trend Analysis

  • 7.1. Protein Binding Assay Market Share, By Region, 2023 & 2030 (USD Million)
  • 7.2. North America
    • 7.2.1. North America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Spain
      • 7.3.5.1. Spain Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Italy
      • 7.3.6.1. Italy Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Norway
      • 7.3.7.1. Norway Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Denmark
      • 7.3.8.1. Denmark Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Sweden Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Kuwait
      • 7.6.4.1. Kuwait Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. South Africa Protein Binding Assay Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Heat Map Analysis
  • 8.4. Company Profiles
    • 8.4.1. Thermo Fisher Scientific
      • 8.4.1.1. Participant's Overview
      • 8.4.1.2. Financial Performance
      • 8.4.1.3. Product Benchmarking
      • 8.4.1.4. Recent Developments/ Strategic Initiatives
    • 8.4.2. ADMEcell, Inc
      • 8.4.2.1. Participant's Overview
      • 8.4.2.2. Financial Performance
      • 8.4.2.3. Product Benchmarking
      • 8.4.2.4. Recent Developments/ Strategic Initiatives
    • 8.4.3. Beckman Coulter, Inc
      • 8.4.3.1. Participant's Overview
      • 8.4.3.2. Financial Performance
      • 8.4.3.3. Product Benchmarking
      • 8.4.3.4. Recent Developments/ Strategic Initiatives
    • 8.4.4. Sartorius Stedim BioOutsource Limited
      • 8.4.4.1. Participant's Overview
      • 8.4.4.2. Financial Performance
      • 8.4.4.3. Product Benchmarking
      • 8.4.4.4. Recent Developments/ Strategic Initiatives
    • 8.4.5. Bio-Rad Laboratories, Inc
      • 8.4.5.1. Participant's Overview
      • 8.4.5.2. Financial Performance
      • 8.4.5.3. Product Benchmarking
      • 8.4.5.4. Recent Developments/ Strategic Initiatives
    • 8.4.6. Abzena Ltd
      • 8.4.6.1. Participant's Overview
      • 8.4.6.2. Financial Performance
      • 8.4.6.3. Product Benchmarking
      • 8.4.6.4. Recent Developments/ Strategic Initiatives
    • 8.4.7. Abcam Plc
      • 8.4.7.1. Participant's Overview
      • 8.4.7.2. Financial Performance
      • 8.4.7.3. Product Benchmarking
      • 8.4.7.4. Recent Developments/ Strategic Initiatives
    • 8.4.8. GVK Biosciences Private Limited
      • 8.4.8.1. Participant's Overview
      • 8.4.8.2. Financial Performance
      • 8.4.8.3. Product Benchmarking
      • 8.4.8.4. Recent Developments/ Strategic Initiatives
    • 8.4.9. Promega Corporation
      • 8.4.9.1. Participant's Overview
      • 8.4.9.2. Financial Performance
      • 8.4.9.3. Product Benchmarking
      • 8.4.9.4. Recent Developments/ Strategic Initiatives
    • 8.4.10. Arryait Corporation
      • 8.4.10.1. Participant's Overview
      • 8.4.10.2. Financial Performance
      • 8.4.10.3. Product Benchmarking
      • 8.4.10.4. Recent Developments/ Strategic Initiatives
    • 8.4.11. Charles River Laboratories
      • 8.4.11.1. Participant's Overview
      • 8.4.11.2. Financial Performance
      • 8.4.11.3. Product Benchmarking
      • 8.4.11.4. Recent Developments/ Strategic Initiatives
    • 8.4.12. Sovicell
      • 8.4.12.1. Participant's Overview
      • 8.4.12.2. Financial Performance
      • 8.4.12.3. Product Benchmarking
      • 8.4.12.4. Recent Developments/ Strategic Initiatives
    • 8.4.13. Eurofins Scientific
      • 8.4.13.1. Participant's Overview
      • 8.4.13.2. Financial Performance
      • 8.4.13.3. Product Benchmarking
      • 8.4.13.4. Recent Developments/ Strategic Initiatives
    • 8.4.14. 3B Pharmaceuticals
      • 8.4.14.1. Participant's Overview
      • 8.4.14.2. Financial Performance
      • 8.4.14.3. Product Benchmarking
      • 8.4.14.4. Recent Developments/ Strategic Initiatives
    • 8.4.15. Creative Biolabs
      • 8.4.15.1. Participant's Overview
      • 8.4.15.2. Financial Performance
      • 8.4.15.3. Product Benchmarking
      • 8.4.15.4. Recent Developments/ Strategic Initiatives
    • 8.4.16. Evotec SE
      • 8.4.16.1. Participant's Overview
      • 8.4.16.2. Financial Performance
      • 8.4.16.3. Product Benchmarking
      • 8.4.16.4. Recent Developments/ Strategic Initiatives
    • 8.4.17. BioDuro-Sundia
      • 8.4.17.1. Participant's Overview
      • 8.4.17.2. Financial Performance
      • 8.4.17.3. Product Benchmarking
      • 8.4.17.4. Recent Developments/ Strategic Initiatives
    • 8.4.18. Merck KGaA
      • 8.4.18.1. Participant's Overview
      • 8.4.18.2. Financial Performance
      • 8.4.18.3. Product Benchmarking
      • 8.4.18.4. Recent Developments/ Strategic Initiatives